Comment on "Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19: A propensity score-matched analysis" by Tseng et al.

Shih, Pei-Yun; Yong, Su-Boon; Wei, James Cheng-Chung

Shih, Pei-Yun; Yong, Su-Boon; Wei, James Cheng-Chung.

Shih PY; School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Yong SB; Division of Pediatric Allergy, Immunology, Rheumatology, Lin-Shin Hospital, Taichung, Taiwan.
Wei JC; Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung 40201, Taiwan. Electronic address: jccwei@gmail.com.

Pharmacol Res ; 185: 106444, 2022 11.

Article in English | MEDLINE | ID: covidwho-2008030

Subject(s)

COVID-19; Humans; Medicine, Chinese Traditional; Propensity Score; SARS-CoV-2

Keywords

COVID-19; NRICM101; NRICM102

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Prognostic study Topics: Traditional medicine Limits: Humans Language: English Journal: Pharmacol Res Journal subject: Pharmacology Year: 2022 Document Type: Article Affiliation country: J.phrs.2022.106444

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google